Danaher Q1 2026: Revenue Hits $5.95B, Up 3.5% Year-Over-Year
DHR|EPS $2.06|Rev $5.95B|Net Income $1.03B Guidance adjusted $8.35 – $8.55|Stock $194.51 Mixed Quarter. Danaher Corporation (DHR) posted Q1 2026 adjusted EPS of $2.06 on revenue of $5.95B, delivering what appears to be a modest quarter for the diagnostics and research tools giant. Revenue climbed 3.5% from $5.74B in Q1 2025, though the muted stock reaction—shares […]
Danaher Q1 2026: Revenue Hits $5.95B, Up 3.5% Year-Over-Year Read More »






